Rep. Diana Harshbarger

Maddy summaryThis bill modifies Social Security Number (SSN) requirements for claiming the Child Tax Credit and Earned Income Tax Credit. It specifies that qualifying SSNs must be issued to U.S. citizens (or under specific Social Security Act provisions) and issued before the tax return due date. The changes apply to tax years beginning after December 31, 2024, and update related tax code references to use "social security number" instead of "taxpayer identification number." These are technical adjustments to eligibility criteria, not new benefits or funding.

Maddy summaryThe Patient’s Choice Act of 2024 prohibits federal agencies from implementing or enforcing a 2023 proposed rule that would have shortened the maximum duration of short-term health insurance plans. It blocks efforts to reduce the current allowable term for these plans below the existing standard, ensuring they can still be offered with an initial term under 12 months and a total duration of up to 3 years (including renewals). This bill directly affects health insurance issuers and consumers who rely on short-term plans as a temporary coverage option. The legislation maintains the current regulatory framework without altering plan requirements or creating new benefits.

Maddy summaryHR 7652, the Oversight of Medicare Billing Code Cost Act, requires the HHS Inspector General to study how Medicare adds, modifies, and removes billing codes used by healthcare providers to bill for services. The study will analyze data sources, trends in code changes, high-growth specialties, and CMS's monitoring of cost and outcome impacts. Within one year of enactment, the Inspector General must report findings and recommendations to Congress. Additionally, starting in 2024, HHS must annually publish reports listing new Medicare billing codes and their associated costs and usage volumes on its public website.

Maddy summaryThe Telehealth Modernization Act of 2024 extends Medicare's temporary telehealth coverage rules permanently, removing the previous 2024 expiration date. It expands who can provide telehealth services by allowing more healthcare professionals (like certain nurse practitioners) to bill Medicare for these services, and ensures Federally Qualified Health Centers and Rural Health Clinics can continue billing for telehealth under existing payment rules after 2024. The bill also explicitly permits audio-only telehealth calls for Medicare coverage and allows telehealth for hospice face-to-face visits and home dialysis assessments as clinically appropriate, without time limits. These changes directly affect Medicare beneficiaries, healthcare providers, and community health centers offering telehealth services.

Maddy summary# Summary of Proposed Legislation This document outlines a comprehensive U.S. legislative proposal with several key components: 1. **Research Restrictions**: - Requires certification from Federal research grant recipients that they are not Chinese citizens or participants in Chinese talent programs - Prohibits employment of Chinese nationals in federally funded research - Requires institutions receiving Federal assistance to agree not to knowingly employ individuals participating in Chinese talent programs 2. **Foreign Gifts and Contracts Disclosure**: - Mandates disclosure of foreign gifts/contracts over $50,000 to universities - Requires public reporting of restricted/conditional gifts/contracts - Creates a searchable public database of foreign gifts to universities - Requires institutions to maintain policies regarding foreign gifts to faculty and staff 3. **Investment Restrictions**: - Restricts tax-exempt organizations from holding investments in "disqualified Chinese companies" (defined as corporations incorporated in China or with significant Chinese government ownership) - Requires annual reporting on such investments - Allows limited waivers with public disclosure 4. **Taiwan Policy**: - Prohibits U.S. government from recognizing PRC claims to sovereignty over Taiwan without Taiwan's consent - Requires U.S. government to treat Taiwan's democratically elected government as the legitimate representative of the people of Taiwan - Requires a strategy to protect U.S. businesses from Chinese coercion efforts 5. **Additional Provisions**: - Requires participants in Chinese talent programs to register as agents of the Chinese government - Amends economic espionage laws to include education and research - Mandates disclosure of certain funds received by visa holders The legislation represents a significant effort to limit Chinese influence in U.S. academic institutions, research, and business sectors while establishing a more robust policy framework regarding Taiwan.

Maddy summaryHR 6427, the Immediate Access for the Terminally Ill Act, allows individuals diagnosed with a terminal illness meeting specific criteria to receive Social Security disability benefits without the standard waiting period. To qualify, a person must have a condition listed on the Social Security Administration's Compassionate Allowance list that has a life expectancy of five years or less with no known cure. If they choose this option, their monthly benefit amount is reduced to 93% of the standard rate, and the election is permanent upon application. This change directly affects terminally ill individuals who qualify under the published list, which the Social Security Commissioner must update every five years.

Maddy summaryHR 6283, the DRUG Act, regulates pharmacy benefit managers (PBMs) to prevent practices that may increase prescription drug costs for consumers. The bill prohibits PBMs from earning revenue based on drug prices or discounts, requiring them to charge flat dollar service fees instead of fees tied to drug costs. It bans PBMs from steering patients to pharmacies they own or control, mandates equal reimbursement for affiliated and non-affiliated pharmacies, and prohibits charging different fees for the same drug. These provisions apply to group health plans, health insurance issuers, and PBMs, with enforcement beginning for plan years starting January 1, 2026. Violations would result in $10,000 daily penalties and require disgorgement of improperly received payments.

Maddy summaryThis bill (HR 5608) allows health insurance issuers in the Affordable Care Act marketplaces to contribute directly to enrollees' health savings accounts (HSAs) instead of reducing cost-sharing (like deductibles) for silver-level high-deductible health plans. It affects individuals enrolled in these specific plans who elect this option, requiring insurers to pay into their HSAs monthly (equal to the cost-sharing reduction they would have received) using a medical-only debit card. Insurers must also offer high-deductible plans as alternatives to standard silver plans and provide public education about this option starting in 2025. The changes apply to months beginning after December 2024, with funds treated as advance payments toward tax credits.

Maddy summaryThe DRA of 2023 adjusts Medicare payment rates for specific durable medical equipment (DME) items that were part of the 2021 competitive bidding program but for which no supplier contracts were finalized. It directly affects DME suppliers and Medicare beneficiaries by establishing a new 2024 payment formula: 90% of the adjusted payment amount plus 10% of the unadjusted fee schedule for eligible items. The bill also extends a temporary transition rule for non-rural areas through December 31, 2024, while delaying a regulatory change until 2025. These provisions aim to stabilize payments for DME items that did not transition to standard pricing under prior rules.

Maddy summaryThe Maintaining Investments in New Innovation Act (HR 5547) extends the exclusivity period for certain advanced drugs from 7 to 11 years. It defines an "advanced drug product" as a drug using genetically targeted technology to change how genes work, such as drugs that suppress or activate gene function. The bill amends the Social Security Act to update the definition of "qualifying single source drug" to include these advanced therapies with the longer exclusivity period. This change directly affects drug manufacturers developing such advanced therapies and influences Medicare's drug coverage rules by delaying generic competition for these specific treatments.